Every year in France, myocardial infarction – known by many as a heart attack – affects around 100,000 people. The reference treatment is urgent dilation of the arteries with the aim of getting the blood circulating to the heart again. This is what specialists call primary angioplasty. The problem is that the injection needed for anticoagulant treatment increases the risk of haemorrhage. However, French researchers are now offering a new therapeutic strategy that appears to be more effective.
Written by: Vincent Roche – Edited by: Emmanuel Ducreuzet
Source : INSERM, 30 October 2013 – Interview with Professor Philippe Gabriel Steg, 30 October 2013